| 000 | 01875 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515125125.0 | ||
| 264 | 0 | _c20081017 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1173-2563 | ||
| 024 | 7 |
_a10.2165/00044011-200828080-00002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSekar, V | |
| 245 | 0 | 0 |
_aEffect of repeated doses of darunavir plus low-dose ritonavir on the pharmacokinetics of sildenafil in healthy male subjects: phase I randomized, open-label, two-way crossover study. _h[electronic resource] |
| 260 |
_bClinical drug investigation _c2008 |
||
| 300 |
_a479-85 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aDarunavir |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aPiperazines _xadministration & dosage |
| 650 | 0 | 4 |
_aPurines _xadministration & dosage |
| 650 | 0 | 4 |
_aRitonavir _xadministration & dosage |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfones _xadministration & dosage |
| 700 | 1 | _aLefebvre, E | |
| 700 | 1 | _aDe Marez, T | |
| 700 | 1 | _aDe Pauw, M | |
| 700 | 1 | _aDe Paepe, E | |
| 700 | 1 | _aVangeneugden, T | |
| 700 | 1 | _aHoetelmans, R M W | |
| 773 | 0 |
_tClinical drug investigation _gvol. 28 _gno. 8 _gp. 479-85 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/00044011-200828080-00002 _zAvailable from publisher's website |
| 999 |
_c18080786 _d18080786 |
||